Document:

Warrant 2 to Ocean Park Advisors, LLC

 Exhibit 10.17 
 WARRANT TO PURCHASE COMMON STOCK 
 THIS WARRANT AND THE SECURITIES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND ANY APPLICABLE STATE
SECURITIES LAWS OR THE AVAILABILITY OF AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT AND ANY APPLICABLE STATE SECURITIES LAWS. 
 WARRANT TO PURCHASE COMMON STOCK 
  

			
	Number of Shares:	    	2,069,109 Shares (subject to adjustment)
		
	Warrant Price:	    	$0.7587 per Share
		
	Issuance Date:	    	September 20, 2006
		
	Expiration Date:	    	September 20, 2011

 THIS WARRANT CERTIFIES THAT for value received, Ocean Park Advisors, LLC, or its registered assigns
(hereinafter called the “Holder”) is entitled to purchase from Diametrics Medical, Inc., a Minnesota corporation (hereinafter called the “Company”), the above referenced number of fully paid and
nonassessable shares (the “Shares”) of common stock, par value $1.00 per share (the “Common Stock”) of Company, at the Warrant Price per Share referenced above; the number of shares purchasable upon
exercise of this Warrant referenced above being subject to adjustment from time to time as described herein. This Warrant is issued in connection with that certain Exercise Agreement dated as of September 20, 2006, by and between the Company
and Holder. The exercise of this Warrant shall be subject to the provisions, limitations and restrictions contained herein. 
 1. Term and
Exercise. 
 1.1 Term. This Warrant is exercisable in whole or in part (but not as to any fractional share of Common Stock), at any time
and from time to time after the later of (x) the first date that the closing sale price of the Company’s Common Stock on the OTC Bulletin Board, the NASDAQ Stock Market, the New York Stock Exchange, the American Stock Exchange or any other
established United States stock exchange (collectively, a “Stock Exchange”) is greater than $1.14 per share, and (y) the date of approval (the “Shareholder Approval Date”) by the shareholders of the Company of either
(i) an amendment to the Company’s Amended and Restated Articles of Incorporation to increase the number of shares of Common Stock that the Company is authorized to issue or (ii) the merger of the Company into a wholly owned subsidiary
of the Company incorporated in the State of Delaware, in either case resulting in a sufficient number of authorized but unissued shares of Common Stock issuable upon exercise of this Warrant; but in any event prior to 6:00 p.m. on the Expiration
Date set forth above. 
 1.2 Warrant Price. The Warrant shall be exercisable at the Warrant Price referenced above. 
 1.3 Maximum Number of Shares. The maximum number of Shares of Common Stock exercisable pursuant to this Warrant is 2,069,109 Shares. 
 1.4 Procedure for Exercise of Warrant. Holder may exercise this Warrant by delivering the following to the principal office of the Company in accordance
with Section 5.1 hereof: (i) a duly executed Notice of Exercise in substantially the form attached as Schedule A, (ii) payment of the Warrant Price then in effect for each of the Shares being purchased, as designated in the
Notice of Exercise, and (iii) this Warrant. Payment of the Warrant Price may be in cash, certified or official bank check payable to the order of the Company, or wire transfer of funds to the Company’s account (or any combination of any of
the foregoing) in the amount of the Warrant Price for each share being purchased. 
 1.5 Delivery of Certificate and New Warrant. In the event
of any exercise of the rights represented by this Warrant, a certificate or certificates for the shares of Common Stock so purchased, registered in the name of the Holder or such other name or names as may be designated by the Holder, together with
any other securities or other property which the Holder is entitled to receive upon exercise of this Warrant, shall be delivered to the Holder hereof, at the Company’s expense, within a reasonable time, not exceeding five (5) trading days,
after the rights represented by this Warrant shall have been so exercised; and, unless this Warrant has expired, a new Warrant representing the number of Shares (except a remaining fractional share), if any, with respect to which this Warrant shall
not then have been exercised shall also be issued to the Holder hereof within such time. The person in whose name any certificate for shares of Common Stock is issued upon exercise of this Warrant shall for all purposes be deemed to have become the
holder of record of such shares on the date on which the Warrant was surrendered and payment of the Warrant Price was received by the Company, irrespective of the date of delivery of such certificate, except that, if the date of such surrender and
payment is on a date when the stock transfer books of the Company are closed, such person shall be deemed to have become the holder of such Shares at the close of business on the next succeeding date on which the stock transfer books are open.

 1.6 Restrictive Legend. Each certificate for Shares shall bear a restrictive legend in substantially the form as follows, together with any
additional legend required by (i) any applicable state securities laws and (ii) any securities exchange upon which such Shares may, at the time of such exercise, be listed: 
 “The shares represented by this certificate have not been registered under the Securities Act of 1933, as amended and may not be sold, offered for
sale, transferred or pledged in the absence of such registration or an exemption therefrom under such Act.” 
 Any certificate issued at any time in
exchange or substitution for any certificate bearing such legend shall also bear such legend unless, in the opinion of counsel for the Holder thereof (which counsel shall be reasonably satisfactory to the Company), the securities represented thereby
are not, at such time, required by law to bear such legend. 
 1.7 Fractional Shares. No fractional Shares shall be issuable upon exercise or
conversion of the Warrant and the number of Shares to be issued shall be rounded down to the nearest whole Share. If a fractional share interest arises upon any exercise or conversion of the Warrant, the Company shall eliminate such fractional share
interest by paying to Holder an amount computed by multiplying the fractional interest by the Warrant Price of a full Share then in effect. 
  

 -1- 

 1.8 Cashless Exercise. 
 (a) Holder may, at its option, in lieu of paying the Warrant Price upon exercise of this Warrant pursuant to Section 1.4 hereof, elect to receive instead a number of Shares computed using the following formula:

 X=Y(A-B) 
           A 
 Where X= the number of Shares issuable to Holder upon
exercise of this Warrant under this Section 1.8, Y=the number of Shares being surrendered under this Warrant, A=the Fair Market Value (as defined below) of one Share of Common Stock as of the exercise date; and B=the Warrant Price of one Share
of Common Stock. 
 (b) For purposes of this Section 1.8, “Fair Market Value” of one Share of Common Stock as of
a particular date shall be determined as follows: (i) if traded on a national securities exchange or through the Nasdaq Stock Market, the Fair Market Value shall be deemed to be the volume weighted average closing price of the Common Stock on
such exchange for the five trading days immediately prior to the date the Holder delivers its Notice of Exercise to the Company (or if no reported sales took place on any of the five days, the last five trading days on which any such sales took
place prior to the date of such notice); (ii) if traded over-the-counter but not on the Nasdaq Stock Market, the Fair Market Value shall be deemed to be the volume weighted average closing price of the Common Stock on such exchange for the five
trading days immediately prior to the date the Holder delivers its Notice of Exercise to the Company (or if no reported sales took place on any of the five days, the last five trading days on which any such sales took place prior to the date of such
notice); and (iii) if there is no active market public market, the Fair Market Value shall be the as mutually determined by the Holder and the Company or, if the Holder and the Company are unable to reach such agreement, as determined by a
nationally recognized independent investment banker or valuation consultant (which has not been retained by the Company or any of its affiliates for the past two years preceding such determination) mutually acceptable to Holder and Company.

 2. Representations, Warranties and Covenants. 
 2.1 Representations and Warranties. 
 (a) The Company is a corporation duly organized, validly existing and in good
standing under the laws of its state of incorporation and has all necessary power and authority to perform its obligations under this Warrant; 
 (b) Subject to the Shareholder Apprival, the execution, delivery and performance of this Warrant has been duly authorized by all necessary actions on the part of the Company and constitutes the legal, valid and binding obligation of the
Company, enforceable against the Company in accordance with its terms; and 
 (c) Subject to the Shareholder Apprival, this Warrant does not
violate and is not in conflict with any of the provisions of the Company’s Amended and Restated Articles of Incorporation, Certificate of Designation, Bylaws and any resolutions of the Company’s Board of Directors or stockholders, or any
agreement of the Company, and no event has occurred and no condition or circumstance exists that might (with or without notice or lapse of time) constitute or result directly or indirectly in such a violation or conflict. 
 2.2 Issuance of Shares. The Company covenants and agrees that all shares of Common Stock that may be issued upon the exercise of the rights
represented by this Warrant will, upon issuance, be validly issued, fully paid and nonassessable, and free from all taxes, liens and charges with respect to the issue thereof and shall be listed on any exchanges on which the Common Stock is then
listed. The Company further covenants and agrees that it will pay when due and payable any and all federal and state taxes which may be payable in respect of the issue of this Warrant or any Common Stock or certificates therefor issuable upon the
exercise of this Warrant excluding the Holder’s income and other taxes not directly relating to the issuance of the Warrant or Common Stock. The Company further covenants and agrees that the Company will at all times have authorized and
reserved, free from preemptive rights, a sufficient number of shares of Common Stock to provide for the exercise in full of the rights represented by this Warrant. If at any time the number of authorized but unissued shares of Common Stock of the
Company shall not be sufficient to effect the exercise of the Warrant in full, subject to the limitations set forth in Section 1.3 hereto, then the Company will take all such corporate action as may, in the opinion of counsel to the Company, be
necessary or advisable to increase the number of its authorized shares of Common Stock as shall be sufficient to permit the exercise of the Warrant in full, subject to the limitations set forth in Section 1.3 hereto, including without
limitation, using its best efforts to obtain any necessary stockholder approval of such increase. The Company further covenants and agrees that if any shares of capital stock to be reserved for the purpose of the issuance of shares upon the exercise
of this Warrant require registration with or approval of any governmental authority under any federal or state law before such shares may be validly issued or delivered upon exercise, then the Company will in good faith and as expeditiously as
possible endeavor to secure such registration or approval, as the case may be. If and so long as the Common Stock issuable upon the exercise of this Warrant is listed on any national securities exchange or the Nasdaq Stock Market, the Company will,
if permitted by the rules of such exchange or market, list and keep listed on such exchange or market, upon official notice of issuance, all shares of such Common Stock issuable upon exercise of this Warrant. 
 3. Other Adjustments. 
 3.1 Subdivision or Combination of
Shares. In case the Company shall at any time subdivide its outstanding Common Stock into a greater number of shares, the Warrant Price in effect immediately prior to such subdivision shall be proportionately reduced, and the number of
Shares subject to this Warrant shall be proportionately increased, and conversely, in case the outstanding Common Stock of the Company shall be combined into a smaller number of shares, the Warrant Price in effect immediately prior to such
combination shall be proportionately increased, and the number of Shares subject to this Warrant shall be proportionately decreased. 
 3.2 Dividends
in Common Stock, Other Stock or Property. If at any time or from time to time the holders of Common Stock (or any shares of stock or other securities at the time receivable upon the exercise of this Warrant) shall have received or become
entitled to receive, without payment therefor: 
 (a) Common Stock, Options or any shares or other securities which are at any time directly
or indirectly convertible into or exchangeable for Common Stock, or any rights or options to subscribe for, purchase or otherwise acquire any of the foregoing by way of dividend or other distribution; 
 (b) any cash paid or payable otherwise than as a regular cash dividend; or 
 (c) Common Stock or additional shares or other securities or property (including cash) by way of spin-off, split-up, reclassification, combination of shares or similar corporate rearrangement (other than Common Stock
issued as a stock split or adjustments in respect of which shall be covered by the terms of Section 3.1 above) or additional shares, other securities or property issued in connection with a Change (as defined below) (which shall be covered by
the terms of Section 3.3 below), then and in each such case, the Holder hereof shall, upon the exercise of this Warrant, be entitled to receive, in addition to the number of shares of Common Stock receivable thereupon, and without payment of
any additional consideration therefor, the amount of stock and other securities and property (including cash in the cases referred to in clause (b) above and this clause (c)) which such Holder would hold on the date of such exercise had such
Holder been the holder of record of such Common Stock as of the date on which holders of Common Stock received or became entitled to receive such shares or all other additional stock and other securities and property. 
  

 -2- 

 3.3 Reorganization, Reclassification, Consolidation, Merger or Sale. If any recapitalization,
reclassification or reorganization of the share capital of the Company, or any consolidation or merger of the Company with another corporation, or the sale of all or substantially all of its shares and/or assets or other transaction (including,
without limitation, a sale of substantially all of its assets followed by a liquidation) shall be effected in such a way that holders of Common Stock shall be entitled to receive shares, securities or other assets or property (a
“Change”), then, as a condition of such Change, lawful and adequate provisions shall be made by the Company whereby the Holder hereof shall thereafter have the right to purchase and receive (in lieu of the Common Stock of the
Company immediately theretofore purchasable and receivable upon the exercise of the rights represented hereby) such shares, securities or other assets or property as may be issued or payable with respect to or in exchange for the number of
outstanding Common Stock which such Holder would have been entitled to receive had such Holder exercised this Warrant immediately prior to the consummation of such Change. The Company or its successor shall promptly issue to Holder a new Warrant for
such new securities or other property. The new Warrant shall provide for adjustments which shall be as nearly equivalent as may be practicable to give effect to the adjustments provided for in this Section 3 including, without limitation,
adjustments to the Warrant Price and to the number of securities or property issuable upon exercise of the new Warrant. The provisions of this Section 3.3 shall similarly apply to successive Changes. 
 4. Ownership and Transfer. 
 4.1 Ownership of This
Warrant. The Company may deem and treat the person in whose name this Warrant is registered as the holder and owner hereof (notwithstanding any notations of ownership or writing hereon made by anyone other than the Company) for all purposes
and shall not be affected by any notice to the contrary until presentation of this Warrant for registration of transfer as provided in this Section 4. 
 4.2 Transfer and Replacement. This Warrant and all rights hereunder are transferable in whole or in part upon the books of the Company by the Holder hereof in person or by duly authorized attorney, and a new Warrant or
Warrants, of the same tenor as this Warrant but registered in the name of the transferee or transferees (and in the name of the Holder, if a partial transfer is effected) shall be made and delivered by the Company upon surrender of this Warrant duly
endorsed, at the office of the Company in accordance with Section 5.1 hereof. Upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft or destruction, and, in such case, of indemnity or security reasonably
satisfactory to it, and upon surrender of this Warrant if mutilated, the Company will make and deliver a new Warrant of like tenor, in lieu of this Warrant; provided that if the Holder hereof is an instrumentality of a state or local government or
an institutional holder or a nominee for such an instrumentality or institutional holder an irrevocable agreement of indemnity by such Holder shall be sufficient for all purposes of this Warrant, and no evidence of loss or theft or destruction shall
be necessary. This Warrant shall be promptly cancelled by the Company upon the surrender hereof in connection with any transfer or replacement. Except as otherwise provided above, in the case of the loss, theft or destruction of a Warrant, the
Company shall pay all expenses, taxes and other charges payable in connection with any transfer or replacement of this Warrant, other than income taxes and stock transfer taxes (if any) payable in connection with a transfer of this Warrant, which
shall be payable by the Holder. Holder will not transfer this Warrant and the rights hereunder except in compliance with federal and state securities laws and except after providing evidence of such compliance reasonably satisfactory to the Company.

 5. Miscellaneous Provisions. 
 5.1
Notices. Any notice or other document required or permitted to be given or delivered to the Holder shall be delivered or forwarded to the Holder at c/o Ocean Park Advisors, LLC, 6033 West Century Blvd., Suite 850, Los Angeles, California
90045, Attention: Heng Chuk (Facsimile No. 310/670-4107), or to such other address or number as shall have been furnished to the Company in writing by the Holder, with a copy to Sidley Austin LLP, 555 West Fifth Street, Suite 4000, Los Angeles,
California 90013 Attention Stephen Blevit (Facsimile No. 213/896-6600). Any notice or other document required or permitted to be given or delivered to the Company shall be delivered or forwarded to the Company at 6033 West Century Blvd., Suite
850, Los Angeles, CA 90045 (facsimile No. (310) 670-4107), or to such other address or number as shall have been furnished to Holder in writing by the Company or to the Company by Holder. 
 5.2 All notices, requests and approvals required by this Warrant shall be in writing and shall be conclusively deemed to be given (i) when hand-delivered to
the other party, (ii) when received if sent by facsimile at the address and number set forth above; provided that notices given by facsimile shall not be effective, unless either (a) a duplicate copy of such facsimile notice is promptly
given by depositing the same in the mail, postage prepaid and addressed to the party as set forth below or (b) the receiving party delivers a written confirmation of receipt for such notice by any other method permitted under this paragraph;
and further provided that any notice given by facsimile received after 5:00 p.m. (recipient’s time) or on a non-business day shall be deemed received on the next business day; (iii) five (5) business days after deposit in the United
States mail, certified, return receipt requested, postage prepaid, and addressed to the party as set forth below; or (iv) the next business day after deposit with an international overnight delivery service, postage prepaid, addressed to the
party as set forth below with next business day delivery guaranteed; provided that the sending party receives confirmation of delivery from the delivery service provider. 
 5.3 No Rights as Shareholder; Limitation of Liability. This Warrant shall not entitle the Holder to any of the rights of a shareholder of the Company except upon exercise in accordance with the terms
hereof. No provision hereof, in the absence of affirmative action by the Holder to purchase shares of Common Stock, and no mere enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the
Warrant Price hereunder or as a shareholder of the Company, whether such liability is asserted by the Company or by creditors of the Company. 
 5.4
Governing Law. This Warrant shall be governed by and construed in accordance with the laws of the State of New York. 
 5.5 Binding Effect
on Successors. This Warrant shall be binding upon any corporation succeeding the Company by merger, consolidation or acquisition of all or substantially all of the Company’s assets and/or securities. All of the obligations of the
Company relating to the Shares issuable upon the exercise of this Warrant shall survive the exercise and termination of this Warrant. All of the covenants and agreements of the Company shall inure to the benefit of the successors and assigns of the
Holder. 
  

 -3- 

 5.6 Waiver, Amendments and Headings. This Warrant and any provision hereof may be changed, waived,
discharged or terminated only by an instrument in writing signed by both parties (either generally or in a particular instance and either retroactively or prospectively). The headings in this Warrant are for purposes of reference only and shall not
affect the meaning or construction of any of the provisions hereof. 
 5.7 Jurisdiction. Each of the parties irrevocably agrees that any and
all suits or proceedings based on or arising under this Agreement may be brought in the federal or state courts located in the City of New York, New York and consents to the jurisdiction of such courts for such purpose. Each of the parties
irrevocably waives the defense of an inconvenient forum to the maintenance of such suit or proceeding in any such court. Each of the parties further agrees that service of process upon such party mailed by first class mail to the address set forth
in Section 5.1 shall be deemed in every respect effective service of process upon such party in any such suit or proceeding. Nothing herein shall affect the right of a Holder to serve process in any other manner permitted by law. Each of the
parties agrees that a final non-appealable judgment in any such suit or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on such judgment or in any other lawful manner. 
 5.8 Attorneys’ Fees and Disbursements. If any action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the
prevailing party or parties shall be entitled to receive from the other party or parties reasonable attorneys’ fees and disbursements in addition to any other relief to which the prevailing party or parties may be entitled. 
 IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by its duly authorized officer this 20th day of September, 2006. 
  

					
	COMPANY:	 	DIAMETRICS MEDICAL, INC.
			
		 	By	 	 /s/ Paul Galleberg

		 	Print Name:	 	Paul Galleberg
		 	Title:	 	Director

  

 -4- 

 SCHEDULE A 
 FORM OF NOTICE OF EXERCISE 
 [To be signed only upon exercise of the Warrant]

 TO BE EXECUTED BY THE REGISTERED HOLDER 
 TO EXERCISE THE WITHIN WARRANT 
 The undersigned hereby elects to purchase
                     shares of Common Stock (the “Shares”) of Diametrics Medical, Inc. under the Warrant to Purchase
Common Stock dated September 20, 2006, which the undersigned is entitled to purchase pursuant to the terms of such Warrant. The undersigned has delivered $            , the
aggregate Warrant Price for                      Shares purchased herewith, in full in cash or by certified or official bank check or wire
transfer. 
 Please issue a certificate or certificates representing such shares of Common Stock in the name of the undersigned or in such
other name as is specified below and in the denominations as is set forth below: 
  

			
	  
	Ocean Park Advisors, LLC
	  
	[Requested Denominations – if no denomination is specified, a single certificate will be issued]
	
	The initial address of such Holder to be entered on the books of Company shall be:
	  	 	
	  	 	
	  	 	

 The undersigned hereby represents and warrants that the undersigned is acquiring such shares for
his own account for investment purposes only, and not for resale or with a view to distribution of such shares or any part thereof. 
  

	
	By:                                      
                                        
                  
	
	Print
Name:                                       
                                       
 
	
	Title:                                     
                                        
               
	
	Dated:                                     
                                        
             

  

 -1- 

 FORM OF ASSIGNMENT 
 (ENTIRE) 
 [To be signed only upon transfer of entire Warrant] 
 TO BE EXECUTED BY THE REGISTERED HOLDER 
 TO TRANSFER THE WITHIN WARRANT 
 FOR VALUE RECEIVED
                                        
hereby sells, assigns and transfers unto                      all rights of the undersigned under and pursuant to the within Warrant, and the
undersigned does hereby irrevocably constitute and appoint
                                        
Attorney to transfer the said Warrant on the books of Diametrics Medical, Inc., with full power of substitution. 
  

			
	  
	Ocean Park Advisors, LLC
		
	By:	 	  

	Title:	 	  

	
	Dated:                     

 NOTICE 
 The
signature to the foregoing Assignment must correspond exactly to the name as written upon the face of the within Warrant, without alteration or enlargement or any change whatsoever. 
  

 -2- 

 FORM OF ASSIGNMENT 
 (PARTIAL) 
 [To be signed only upon partial transfer of Warrant] 
 TO BE EXECUTED BY THE REGISTERED HOLDER 
 TO TRANSFER THE WITHIN WARRANT 
 FOR VALUE RECEIVED
                                        
hereby sells, assigns and transfers unto                      (i) the rights of the undersigned to purchase
                         shares of Common Stock under and pursuant to the within Warrant, and (ii) on a non-exclusive
basis, all other rights of the undersigned under and pursuant to the within Warrant, it being understood that the undersigned shall retain, severally (and not jointly) with the transferee(s) named herein, all rights assigned on such non-exclusive
basis. The undersigned does hereby irrevocably constitute and appoint
                                        
Attorney to transfer the said Warrant on the books of Diametrics Medical, Inc., with full power of substitution. 
  

			
	  
	Ocean Park Advisors, LLC
		
	By:	 	  

	Title:	 	  

	
	Dated:                     

 NOTICE 
 The
signature to the foregoing Assignment must correspond exactly to the name as written upon the face of the within Warrant, without alteration or enlargement or any change whatsoever. 
  

 -3-Stock Option Agreement - Ocean Park Advisors, LLC

 Exhibit 10.18 
 NEITHER THIS SECURITY NOR THE SHARES OF STOCK ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (AS AMENDED, THE “SECURITIES ACT”) OR UNDER THE SECURITIES LAWS OF ANY STATE. NEITHER THIS
SECURITY NOR THE SHARES OF STOCK ISSUED UPON EXERCISE HEREOF MAY BE TRANSFERRED, SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND EXEMPTION OR QUALIFICATION UNDER ANY
APPLICABLE STATE SECURITIES LAWS AND, IF REQUESTED BY THE COMPANY, DELIVERY TO THE COMPANY OF AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED. ANY ATTEMPT TO TRANSFER, SELL, PLEDGE OR HYPOTHECATE
THIS SECURITY OR SUCH SHARES IN VIOLATION OF THESE RESTRICTIONS SHALL BE VOID. THE TRANSFER OF THIS SECURITY AND THE SHARES OF STOCK ISSUABLE UPON EXERCISE HEREOF ARE ALSO RESTRICTED BY THIS AGREEMENT. 
 DIAMETRICS MEDICAL, INC. 
 STOCK
OPTION AGREEMENT 
 PURSUANT TO 2006 INCENTIVE COMPENSATION PLAN 
 Ocean Park Advisors, LLC (the “Optionee”) is hereby granted an option (the “Option”) to purchase shares of the
Common Stock of Diametrics Medical, Inc., a Minnesota corporation (the “Company”) pursuant to this Stock Option Agreement (this “Agreement”) and the Company’s 2006 Incentive Compensation Stock Option Plan (as
amended, the “Plan”), the provisions of which are incorporated herein by reference. 
 1. TERMS OF GRANT.

 “Date of Option Grant” means September 20, 2006. 
 “Option Shares” means 2,069,109 shares of Common Stock; $1.00 per share, of the Company. 
 “Exercise Price” means $0.7587 per share of Common Stock 
 “Vesting Date” means the later of (x) the first date that the closing sale price of the Company’s Common Stock on the OTC Bulletin Board, the NASDAQ Stock Market, the New York Stock
Exchange, the American Stock Exchange or any other established United States stock exchange is greater than $1.33 per share and (y) the date of approval by the shareholders of the Company of either (i) an amendment to the Company’s
Amended and Restated Articles of Incorporation to increase the number of shares of Common Stock that the Company is authorized to issue or (ii) the merger of the Company into a wholly owned subsidiary of the Company incorporated in the State of
Delaware, in either case resulting in a sufficient number of authorized but unissued shares of Common Stock issuable upon exercise of this Option. 
 “Option Expiration Date” means September 20, 2011. 
 2. DEFINITIONS AND CONSTRUCTION.

 2.1 Definitions. Unless otherwise defined herein, capitalized terms shall have the meanings assigned to such terms in the Plan.

 2.2 Construction. Captions and titles contained herein are for convenience only and shall not affect the meaning or interpretation
of any provision of this Agreement. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term “or” is not intended to be exclusive, unless the context
clearly requires otherwise. 

	 	3.	TAX CONSEQUENCES. 

 The Option is intended to
constitute an “incentive stock option” as that term is used in Code Section 422. To the extent that the aggregate fair market value (determined at the time of grant) of Option Shares with respect to which incentive stock options are
exercisable for the first time by the Participant during any calendar year under all plans of the Company and its subsidiaries exceeds $100,000, the options or portions thereof which exceed such limit (according to the order in which they were
granted) shall be treated as nonstatutory stock options. It should be understood that there is no assurance that the Option will, in fact, be treated as an incentive stock option. The Optionee should consult with the Optionee’s own tax advisor
regarding the tax effects of this Option (and any requirements necessary to obtain favorable income tax treatment under Code Section 422, including, but not limited to, holding period requirements). If the Option is treated as an Incentive
Stock Option in part and as a Nonstatutory Stock Option in part by reason of the limitation set forth in this Section 3, the Optionee may designate which portion of such Option the Optionee is exercising. 
 4. EXERCISE OF THE OPTION. 
 4.1 Right to Exercise. Except as otherwise provided herein, the Option shall be exercisable in full on and after the Vesting Date and prior to the termination of the Option (as provided in Section 6). 
 4.2 Method of Exercise. Exercise of the Option shall be by written notice to the Company in the form of Exhibit A and Exhibit B
hereto. The written notice must be signed by the Optionee and must be delivered in person, by certified or registered mail, return receipt requested, by confirmed facsimile transmission, or by such other means as the Company may permit, to the Chief
Executive Officer of the Company, or other authorized representative of the Company, prior to the termination of the Option as set forth in Section 6, accompanied by full payment of the aggregate Exercise Price for the number of Option Shares
being purchased. The Option shall be deemed to be exercised upon receipt by the Company of such written notice and the aggregate Exercise Price. 
 4.3 Payment of Exercise Price. 
 (a) Forms of Consideration Authorized. Except as otherwise provided below,
payment of the aggregate Exercise Price for the number of Option Shares for which the Option is being exercised shall be made (i) in cash, by check or cash equivalent, (ii) by tender to the Company of whole Option Shares owned by the
Optionee having a Fair Market Value not less than the aggregate Exercise Price (iii) by retention by the Company of that number of Options Shares (the “Retained Shares”) having an aggregate Fair Market Value on the date of
exercise equal to the aggregate exercise price for all Option Shares for which the Option is being exercised, so that the Optionee receives the number of Option Shares for which the Option is exercised less the Retained Shares or (iv) by any
combination of the foregoing. If the Retained Shares include a fractional share, the Retained Shares will be rounded up to the nearest whole share. 
 (b) Limitations on Forms of Consideration. Notwithstanding the foregoing, the Option may not be exercised by tender to the Company of Option Shares to the extent such tender, or attestation to the
ownership, of Stock would constitute a violation of the provisions of any law, regulation or agreement restricting the redemption of the Company’s stock. The Option may not be exercised by tender to the Company of shares of Stock unless such
shares either have been owned by the Optionee for more than six (6) months or were not acquired, directly or indirectly, from the Company. 
 4.4 Tax Withholding. At the time the Option is exercised, in whole or in part, or at any time thereafter as requested by the Company, the Optionee hereby authorizes withholding from payroll and any other amounts payable to the
Optionee, and otherwise agrees to make adequate provision for any sums required to satisfy the federal, state, local and foreign tax withholding obligations of the Company, if any, which arise in connection with the Option, including, without
limitation, obligations arising upon (i) the exercise, in whole or in part, of the Option, (ii) the transfer, in whole or in part, of any 
  

 2 

 Option Shares acquired upon exercise of the Option, (iii) the operation of any law or regulation providing for the
imputation of interest, or (iv) the lapsing of any restriction with respect to any shares acquired upon exercise of the Option. The Optionee is cautioned that the Option is not exercisable unless the tax withholding obligations of the Company
are satisfied. Accordingly, the Optionee may not be able to exercise the Option when desired even though the Option is vested, and the Company shall have no obligation to issue a certificate for such shares. 
 4.5 Certificate Registration. The certificate for the Option Shares as to which the Option is exercised shall be registered in the name of the
Optionee, or, if applicable, the Optionee’s heirs. 
 4.6 Restrictions on Grant of the Option and Issuance of Shares. The grant
of the Option and the issuance of Option Shares upon exercise of the Option shall be subject to compliance with all applicable requirements of federal, state or foreign law with respect to such securities. The Option may not be exercised if the
issuance of Option Shares upon exercise would constitute a violation of any applicable federal, state or foreign securities laws or other law or regulations or the requirements of any stock exchange or market system upon which the Stock may then be
listed. THE OPTIONEE IS CAUTIONED THAT THE OPTION MAY NOT BE EXERCISED UNLESS THE FOREGOING CONDITIONS ARE SATISFIED. ACCORDINGLY, THE OPTIONEE MAY NOT BE ABLE TO EXERCISE THE OPTION WHEN DESIRED EVEN THOUGH THE OPTION IS VESTED. The inability of
the Company to obtain from any regulatory body having jurisdiction the authority, if any, deemed by the Company’s legal counsel to be necessary to the lawful issuance and sale of any shares subject to the Option shall relieve the Company of any
liability in respect of the failure to issue or sell such shares as to which such requisite authority shall not have been obtained. As a condition to the exercise of the Option, the Company may require the Optionee to satisfy any qualifications that
may be necessary or appropriate, to evidence compliance with any applicable law or regulation and to make any representation or warranty with respect thereto as may be requested by the Company. 
 4.7 Fractional Shares. The Company shall not be required to issue fractional shares upon the exercise of the Option. 
 5. NONTRANSFERABILITY OF THE OPTION AND OPTION SHARES. 
 The Option may be exercised during the lifetime of the Optionee only by the Optionee or the Optionee’s guardian or legal representative and may not be assigned or transferred in any manner except by will or by the laws of descent and
distribution. Following the death of the Optionee, the Option, to the extent provided in Section 7, may be exercised by the Optionee’s legal representative or by any person empowered to do so under the deceased Optionee’s will or
under the then applicable laws of descent and distribution. 
 6. TERMINATION OF THE OPTION. 
 The Option shall terminate and may no longer be exercised on the first to occur of (a) the Option Expiration Date or (b) the last date for
exercising the Option following termination of the Optionee’s Service as described in Section 7. 
 7. EFFECT OF TERMINATION
OF SERVICE. 
 7.1 Option Exercisability. 
 (a) Disability. If the Optionee’s employment with or service to the Company (“Service”) is terminated because of the Disability of the Optionee, the Option, to the extent
unexercised and exercisable on the date on which the Optionee’s Service terminated, may be exercised by the Optionee (or the Optionee’s guardian or legal representative) at any time prior to the expiration of three years after the date on
which the Optionee’s Service terminated, but in any event no later than the Option Expiration Date. (NOTE: If an Incentive Stock Option is exercised more than three (3) months after the 
  

 3 

 date on which the Optionee’s Service as an Employee terminated as a result of a Disability other than a permanent
and total disability as defined in Section 22(e)(3) of the Code, the Option will be treated as a Nonstatutory Stock Option and not as an Incentive Stock Option to the extent required by Section 422 of the Code.) 
 (b) Death. If the Optionee’s Service is terminated because of the death of the Optionee, the Option, to the extent unexercised and
exercisable on the date on which the Optionee’s Service terminated, may be exercised by the Optionee’s legal representative or other person who acquired the right to exercise the Option by reason of the Optionee’ s death at any time
prior to the expiration of three years after the date on which the Optionee’s Service terminated, but in any event no later than the Option Expiration Date. The Optionee’s Service shall be deemed to have terminated on account of death if
the Optionee dies within thirty (30) days after the Optionee’s termination of Service (other than for Cause). 
 (c)
Cause. If the Optionee’s Service is terminated for Cause, the Option shall terminate and cease to be exercisable immediately upon such termination of Service. 
 (d) Other Termination of Service. If the Optionee’s Service terminates for any reason, except Disability, death or for Cause, the
Option, to the extent unexercised and exercisable by the Optionee on the date on which the Optionee’s Service terminated, may be exercised by the Optionee within three years (or such other longer period of time as determined by the Board, in
its sole discretion) after the date on which the Optionee’s Service terminated, but in any event no later than the Option Expiration Date. 
 7.2 Extension if Exercise Prevented by Law. Notwithstanding the foregoing, if the exercise of the Option within the applicable time periods set forth in Section 7.1 is prevented by the provisions of Section 4.6, the Option
shall remain exercisable until thirty (30) days after the date the Optionee is notified by the Company that the Option is exercisable, but in any event no later than the Option Expiration Date. The Company makes no representation as to the tax
consequences of any such delayed exercise. The Optionee should consult with the Optionee’s own tax advisor as to the tax consequences of any such delayed exercise. 
 7.3 Extension if Optionee Subject to Section 16(b). Notwithstanding the foregoing, if a sale within the applicable time periods set forth in Section 7.1 of shares acquired upon the exercise of the
Option would subject the Optionee to suit under Section 16(b) of the Exchange Act, the Option shall remain exercisable until the earliest to occur of (i) the tenth (10th) day following the date on which a sale of such shares by the
Optionee would no longer be subject to such suit, (ii) the one hundred and ninetieth (190th) day after the Optionee’s termination of Service, or (iii) the Option Expiration Date. The Company makes no representation as to the tax
consequences of any such delayed exercise. The Optionee should consult with the Optionee’s own tax advisor as to the tax consequences of any such delayed exercise. 
 8. RIGHTS AS A STOCKHOLDER, EMPLOYEE OR CONSULTANT. 
 The Optionee shall have no rights as a
stockholder with respect to any shares covered by the Option until the date of the issuance of a certificate for the shares for which the Option has been exercised (as evidenced by the appropriate entry on the books of the Company or of a duly
authorized transfer agent of the Company). No adjustment shall be made for dividends, distributions or other rights for which the record date is prior to the date such certificate is issued. Nothing in this Agreement shall confer upon the Optionee
any right to continue in Optionee’s Service or interfere in any way with any right of the Company to terminate the Optionee’s Service at any time. 
  

 4 

 9. NOTICE OF SALES UPON DISQUALIFYING DISPOSITION. 
 If the Option is an Incentive Stock Option, the Optionee shall comply with the provisions of this Section 9. The Optionee shall promptly notify the
Chief Financial Officer of the Company if the Optionee disposes of any of the shares acquired pursuant to the Option within one (1) year after the date of the Optionee exercises all or part of the Option or within two (2) years after the
Date of Grant. Until such time as the Optionee disposes of such shares in a manner consistent with the provisions of this Agreement, unless otherwise expressly authorized by the Company, the Optionee shall hold all shares acquired pursuant to the
Option in the Optionee’s name (and not in the name of any nominee) for the one-year period immediately after the exercise of the Option and the two-year period immediately after Date of Grant. At any time during the one-year or two-year periods
set forth above, the Company may place a legend on any certificate representing shares acquired pursuant to the Option requesting the transfer agent for the Company’s stock to notify the Company of any such transfers. The obligation of the
Optionee to notify the Company of any such transfer shall continue notwithstanding that a legend has been placed on the certificate pursuant to the preceding sentence. 
 10. LEGENDS. 
 The Company may at any time place legends referencing the this Agreement and any
applicable federal, state or foreign securities law restrictions on all certificates representing Option Shares subject to the provisions of this Agreement. The Optionee shall, at the request of the Company, promptly present to the Company any and
all certificates representing Option Shares acquired pursuant to the Option in the possession of the Optionee in order to carry out the provisions of this Section 10. Unless otherwise specified by the Company, legends placed on such
certificates may include, but shall not be limited to, the following: 
 10.1 “THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE SALE IS MADE IN ACCORDANCE WITH
RULE 144 OR RULE 701 UNDER THE ACT, OR THE COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF THESE SECURITIES REASONABLY SATISFACTORY TO THE COMPANY, STATING THAT SUCH SALE, TRANSFER, ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE
REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF SUCH ACT.” 
 10.2 “THE TRANSFER, SALE, ASSIGNMENT, PLEDGE, MORTGAGE,
HYPOTHECATION, ENCUMBRANCE, GIFT OR OTHER DISPOSITION OF SHARES REPRESENTED BY THIS CERTIFICATE IS RESTRICTED BY A STOCK OPTION AGREEMENT, A COPY OF WHICH MAY BE OBTAINED FROM THE COMPANY.” 
 10.3 If Option Shares are issued with respect to an Incentive Stock Option: “THE SHARES EVIDENCED BY THIS CERTIFICATE WERE ISSUED BY THE COMPANY
TO THE REGISTERED HOLDER UPON EXERCISE OF AN INCENTIVE STOCK OPTION AS DEFINED IN SECTION 422 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (“ISO”).” 
 11. REPRESENTATIONS AND WARRANTIES OF THE OPTIONEE. 
 11.1 Optionee hereby confirms, that this Option is and the Option Shares will be acquired for investment for the Optionee’s own account, not as a nominee or agent, and not with a view to the resale or
distribution of any part thereof, and that the Optionee has no present intention of selling, granting any participation in, or otherwise distributing such Option Shares. Optionee further represents that he does not presently have any contract,
undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to any Person, with respect to this Option or any of the Option Shares. 
  

 5 

 11.2 Optionee has had an opportunity to ask questions of and receive answers from the Company regarding
business, management and financial affairs of the Company and the terms and conditions of the offering of the this Option and the Option Shares. 
 11.3 Optionee understands that this Option is and the Option Shares not been registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other
things, the bona fide nature of the investment intent and the accuracy of Optionee’s representations as expressed herein. Optionee understands that this Option is and the Option Shares are “restricted securities” under applicable
federal and state securities laws and that, pursuant to these laws, the Optionee must hold this Option is and the Option Shares indefinitely unless they are registered with the SEC and qualified by state authorities, or an exemption from such
registration and qualification requirements is available. Optionee acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of
sale, the holding period for the Option and the Option Shares, and on requirements relating to the Company that are outside of the Optionee’s control, and which the Company is under no obligation and may not be able to satisfy. 
 11.4 Optionee is an “accredited investor” as defined in Rule 501(a) of Regulation D promulgated under the Securities Act. 
 12. RESTRICTIONS ON TRANSFER OF SHARES. 
 No shares acquired upon exercise of the Option may be sold, exchanged, transferred (including, without limitation, any transfer to a nominee or agent of the Optionee), assigned, pledged, hypothecated or otherwise
disposed of, including by operation of law, in any manner which violates any of the provisions of this Agreement, and any such attempted disposition shall be void. The Company shall not be required (a) to transfer on its books any shares which
will have been transferred in violation of any of the provisions set forth in this Option Agreement or (b) to treat as owner of such shares or to accord the right to vote as such owner or to pay dividends to any transferee to whom such shares
will have been so transferred. 
 13. BINDING EFFECT. 
 Subject to the restrictions on transfer set forth herein, this Agreement shall inure to the benefit of and be binding upon the parties hereto and their
respective heirs, executors, administrators, successors and assigns. 
 14. TERMINATION OR AMENDMENT. 
 The Board may terminate or amend the Plan or the Option at any time; provided, however, that no such termination or amendment may adversely affect the
Option or any unexercised portion hereof without the consent of the Optionee unless such termination or amendment is necessary to comply with any applicable law or government regulation or is required to enable the Option designated as an Incentive
Stock Option in Section 1 to qualify as an Incentive Stock Option. No amendment or addition to this Agreement shall be effective unless in writing. 
 15. NOTICES. 
 Any notice required or permitted hereunder shall be given in writing and shall
be deemed effectively given (except to the extent that this Option Agreement provides for effectiveness only upon actual receipt of such notice) upon personal delivery or upon deposit in the United States Post Office, by registered or certified
mail, with postage and fees prepaid, addressed to the other party at the address set forth below or at such other address as such party may designate in writing from time to time to the other party. 
  

 6 

 16. INTEGRATED AGREEMENT. 
 This Agreement and the Plan constitute the entire understanding and agreement of the Optionee and the Company with respect to the subject matter contained
herein and therein and there are no agreements, understandings, restrictions, representations, or warranties among the Optionee and the Company with respect to such subject matter other than those as set forth or provided for herein or therein. To
the extent contemplated herein or therein, the provisions of this Agreement shall survive any exercise of the Option and shall remain in full force and effect. 
 17. APPLICABLE LAW. 
 This Agreement shall be governed by and construed in accordance with the
internal laws of the State of Minnesota, or if the Company is reincorporated in another state by merger or otherwise, the laws of such other state, and construed in accordance therewith without giving effect to principles of conflicts of law.

 [Signature Page Follows] 
  

 7 

 By their signatures below, the parties hereto agree that the Option is governed by the terms and
conditions of the Plan as in effect on the Date of Option Grant, which is attached hereto. The Optionee acknowledges receipt of a copy of the Plan, represents that he or she is familiar with the provisions contained therein, and hereby accepts the
Option subject to all of the terms and conditions thereof. 
  

							
	OCEAN PARK ADVISORS, LLC	 	DIAMETRICS MEDICAL, INC.
				
	By:	 	 /s/ W. Bruce Comer III
	 	By:	 	 /s/ Paul A. Galleberg

	Name:	 	W. Bruce Comer III	 	Name:	 	Paul A. Galleberg
	Title:	 	Chief Executive Officer	 	Title:	 	Director
		
	Address:	 	Address:
	5710 Crescent Park East., Suite 334	 	6033 West Century Blvd., Suite 850
	Playa Vista, CA 90094	 	Los Angeles, CA 90045

 Attachment:        2006 Incentive Compensation Plan 
  

 8 

 EXHIBIT A 
 OPTION EXERCISE NOTICE 
 Diametrics Medical, Inc. 
 6033 West Century Blvd., Suite 850 
 Los Angeles, CA 90045 
 Attn: Secretary 
 Ladies and Gentlemen: 
 This constitutes
notice that, as of the date this notice and payment of the exercise price is received by the Secretary of Diametrics Medical, Inc. (the “Company”), the Optionee is electing to exercise the stock option granted under Company’s
2006 Incentive Compensation Plan (the “Plan”) and identified below, and to purchase the number of shares for the price set forth below: 
  

			
	Grant Date of stock option:	 	______________________________________
		
	If both incentive stock options and nonstatutory stock options were granted to the Participant on that date, indicate type of option being exercised:	 	        Incentive Stock Option
  

      Non-qualified Stock Option

		
	Number of shares as to which option is exercised:	 	_______________
		
	Stock certificate to be issued in name of:	 	______________________________________
		
	Total exercise price:	 	$                    
		
	Cash payment delivered with this election:	 	$                    
		
	Principal amount of promissory note delivered with this election:	 	$                    
		
	Value of          shares of common stock delivered with this election:1	 	$                    

	1	This alternative applies only if shares meet the public trading requirements. Shares must be valued in accordance with the terms of the option being exercised, must have been owned
for the minimum period required in the option, and must be owned free and clear of any liens, claims, encumbrances or security interests. Certificates must be endorsed or accompanied by an executed assignment separate from the certificate.

  

 9 

 By this exercise, the Participant agrees (i) to provide such additional documents as the Company may
require pursuant to the terms of the Plan, and (ii) to provide for the payment to the Company (in the manner determined by the Company) of amounts required to satisfy the Company’s withholding obligation, if any, relating to this option
exercise. The Participant also acknowledges having received, read and understood the Plan, and agrees to abide by and be bound by its terms and conditions. 
  

					
	 Submitted by:
 OCEAN PARK ADVISORS, LLC
	 	 Accepted by:
 DIAMETRICS MEDICAL,
INC.

			
	  
	 	By:	 	  

	Signature	 		 	
			
	  
	 	Its:	 	  

	Print Name	 		 	
		
	 Address:
  
 5710 Crescent Park East., Suite 334
 Playa Vista, CA 90094
	 	Date Received:
                        

  

 10 

 EXHIBIT B 
 INVESTMENT REPRESENTATION STATEMENT 
 [This form is to be completed at the time option is exercised,

 unless stock is publicly traded at that time.] 
 Effective as of                      [insert date of option exercise] (the “Effective
Date”), the undersigned (“Optionee”) has elected to purchase              shares of the Common Stock, par value $0.01 per share (the
“Shares”), of Diametrics Medical, Inc., a Minnesota corporation (the “Company”) under and pursuant to the Company’s 2006 Incentive Compensation Plan (the “Plan”) and the Stock Option Agreement dated
             [insert grant date of option] (the “Option Terms”). The Optionee hereby makes the following certifications, representations, warranties and
agreements with respect to the purchase of the Shares: 
 The Optionee acknowledges that he or she is aware of the Company’s business
affairs and financial condition and has acquired sufficient information about the Company to reach an informed and knowledgeable decision to acquire the Shares. The Optionee represents and warrants to the Company that he or she is acquiring these
Shares for investment for the Optionee’s own account only and not with a view to, or for resale in connection with, any “distribution” thereof within the meaning of the Securities Act of 1933, as amended (the “Securities
Act”). 
 The Optionee further acknowledges that the Shares have not been registered under the Securities Act, are deemed to
constitute “restricted securities” under Rule 701 and Rule 144 promulgated under the Securities Act and must be held indefinitely unless they are subsequently registered under the Securities Act and qualified under any applicable state
securities laws or an exemption from such registration and qualification is available. The Optionee further acknowledges that the Company is under no obligation to register the Shares. 
 The Optionee further acknowledges that he or she is familiar with the provisions of Rule 701 and Rule 144, which Rules, in substance, permit limited
public resale of “restricted securities” acquired, directly or indirectly from the issuer thereof, in a non-public offering subject to the satisfaction of certain conditions. The Optionee understands that if the Company becomes subject to
the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Optionee will not be able to resell the Shares under Rule 701 (i) until at least ninety (90) days after the Company became subject to such
reporting requirements (or any longer stand-off period, as discussed below, may require) and (ii) unless such resale satisfies those provisions of Rule 144 that are specified in Rule 701(g)(3). Even if the Company is not subject to such
reporting requirements, the Shares may be resold in certain limited circumstances subject to satisfaction of all of the applicable provisions of Rule 144. The Optionee further acknowledges that in the event all of the applicable requirements of Rule
144 are not satisfied, registration under the Securities Act, compliance with Regulation A, or some other registration exemption will be required in order to resell the Shares. The Optionee understands that no assurances can be given that any such
registration will be made or any such exemption will be available in such event. 
 The Optionee further acknowledges and understands that
all certificates representing any of the Shares shall have endorsed thereon appropriate legends reflecting the foregoing limitations, as well as any legends reflecting any other restrictions pursuant to the Company’s Articles of Incorporation,
Bylaws, the Option Terms, the Plan and/or applicable securities laws. 
 The Optionee further agrees that, if so requested by the Company or
any representative of the underwriters (the “Managing Underwriter”) in connection with any registration of the offering of any securities of the Company under the Securities Act, the Optionee shall not sell or otherwise transfer any
Shares or other securities of the Company during the 180-day period, or such other period as may be requested in writing by the Managing Underwriter and agreed to in writing by the Company (the “Market Standoff Period”), following
the effective date of a registration statement of the Company filed under the Securities Act. Such restriction shall apply only to the first registration statement of the Company to 

 become effective under the Securities Act that includes securities to be sold on behalf of the Company to the public in
an underwritten public offering under the Securities Act. The Company may impose stop-transfer instructions with respect to securities subject to the foregoing restrictions until the end of such Market Standoff Period. 
 The Optionee further acknowledge and agrees that the Company shall not be required (i) to transfer on its books any Shares that have been sold or
otherwise transferred in violation of any of the representations, warranties, agreements or other provisions contained in this Notice of Exercise or (ii) to treat as owner of such Shares or to accord the right to vote or pay dividends to any
purchaser or other transferee to whom such Shares shall have been so transferred. 
  

			
	OCEAN PARK ADVISORS, LLC
		
	By:	 	  

	Name:	 	
	Title:	 	

  

 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}]]